For 2016 MM&M enhanced the program with the addition of several new categories.
Discover why even digitally native physicians can no longer abide the flood of information e-sent their way.
Welcome to the mobile era for clinical trials, in which phone and tablet technology promise to upend a costly and unwieldy process.
Manufacturers team up to study drug combinations, a strategy expected to advance the category.
Payer pressure was once again voted the biggest challenge by respondents, and medium and large biopharma and medical device companies appeared to be most bothered by it.
“Globally, you’re seeing a lot more unbranded campaigns,” he explains.